hydromorphone hydrochloride
Generic: hydromorphone hydrochloride
Labeler: hospira, inc.Drug Facts
Product Profile
Brand Name
hydromorphone hydrochloride
Generic Name
hydromorphone hydrochloride
Labeler
hospira, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
hydromorphone hydrochloride .5 mg/.5mL
Manufacturer
Identifiers & Regulatory
Product NDC
0409-4264
Product ID
0409-4264_766e302a-2d03-4d93-b237-2348b57ee517
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA200403
DEA Schedule
cii
Listing Expiration
2027-12-31
Marketing Start
2022-05-27
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04094264
Hyphenated Format
0409-4264
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
hydromorphone hydrochloride (source: ndc)
Generic Name
hydromorphone hydrochloride (source: ndc)
Application Number
NDA200403 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/.5mL
Packaging
- 10 SYRINGE in 1 CELLO PACK (0409-4264-01) / .5 mL in 1 SYRINGE (0409-4264-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "766e302a-2d03-4d93-b237-2348b57ee517", "openfda": {"unii": ["L960UP2KRW"], "rxcui": ["897756", "897757", "1433251", "1724383", "1724644", "2675350"], "spl_set_id": ["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE in 1 CELLO PACK (0409-4264-01) / .5 mL in 1 SYRINGE (0409-4264-11)", "package_ndc": "0409-4264-01", "marketing_start_date": "20220527"}], "brand_name": "Hydromorphone Hydrochloride", "product_id": "0409-4264_766e302a-2d03-4d93-b237-2348b57ee517", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "0409-4264", "dea_schedule": "CII", "generic_name": "HYDROMORPHONE HYDROCHLORIDE", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydromorphone Hydrochloride", "active_ingredients": [{"name": "HYDROMORPHONE HYDROCHLORIDE", "strength": ".5 mg/.5mL"}], "application_number": "NDA200403", "marketing_category": "NDA", "marketing_start_date": "20220527", "listing_expiration_date": "20271231"}